SCHEMBL7355017

SCHEMBL7355017

COC(=O)CN(C1CCC(O)CC1)S(=O)(=O)c1ccc(OC)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 5/20 0.48
NFE2L2 Q16236 4/20 0.48
ALDH1A1 P00352 3/20 0.47
TSHR P16473 1/20 0.47
HTT P42858 1/20 0.47
ATM Q13315 1/20 0.47
KCNA5 P22460 1/20 0.47
LMNA P02545 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CNR1 P21554 1/20 0.46
CNR2 P34972 1/20 0.46
AVPR1B P47901 2/20 0.46
BACE1 P56817 1/20 0.45
MMP3 P08254 3/20 0.45
PKM P14618 1/20 0.45
MMP13 P45452 5/20 0.45
MMP2 P08253 2/20 0.45
MMP1 P03956 3/20 0.44
MMP9 P14780 2/20 0.44
MMP7 P09237 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7359705 0.90 KEAP1 (0.56) KEAP1NFE2L2ALDH1A1TSHRHTT
SCHEMBL7349521 0.87 CNR1 (0.47) KEAP1NFE2L2ALDH1A1TSHRHTT
SCHEMBL7346430 0.86 KEAP1 (0.44) KEAP1NFE2L2ALDH1A1TSHRHTT
SCHEMBL7351711 0.85 KCNA5 (0.53) KEAP1NFE2L2ALDH1A1TSHRHTT
SCHEMBL7342866 0.79 CNR1 (0.60) KEAP1NFE2L2ALDH1A1TSHRHTT
SCHEMBL7344502 0.78 CNR1 (0.53) ALDH1A1TSHRHTTATMKCNA5
SCHEMBL6413655 0.77 MMP3 (0.66) ALDH1A1TSHRHTTATMLMNA
SCHEMBL1936190 0.75 MEN1 (0.45) HTT
SCHEMBL7560825 0.75 ALOX15 (0.49) ALDH1A1LMNANPSR1PKM
SCHEMBL8015046 0.74 KCNA5 (0.56) KEAP1NFE2L2ALDH1A1TSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0766672-B1 ARYLSULFONAMIDO-SUBSTITUTED HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS NOVARTIS AG (CH) 2000-10-04 EP disclosed
US-5672615-A MATRIX-DEGRADING METALLOPROTEINASE INHIBITORS NOVARTIS CORPORATION (US) 1997-09-30 US disclosed
US-5646167-A ADMINISTERED AS METALLOPROTEINASE INHIBITOR, ANTITUMOR OR ANTICARCINOGENIC AGENT CIBA-GEIGY CORPORATION (US) 1997-07-08 US disclosed
EP-0766672-A1 ARYLSULFONAMIDO-SUBSTITUTED HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS Novartis AG (CH) 1997-04-09 EP disclosed
US-5552419-A METALLOPROTEINASE INHIBITORS CIBA-GEIGY CORPORATION (US) 1996-09-03 US disclosed
US-5506242-A METALLOELASTASE INHIBITOR; TREATS EMPHYSEMA CIBA-GEIGY CORPORATION (US) 1996-04-09 US disclosed
WO-1996000214-A1 ARYLSULFONAMIDO-SUBSTITUTED HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS CIBA-GEIGY AG (CH) 1996-01-04 WO disclosed